Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-03-08 @ 11:26 PM
Study NCT ID:
NCT00547651
Status:
COMPLETED
Last Update Posted:
2019-11-06
First Post:
2007-10-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Small Cell Lung Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Small Cell Lung Cancer | View |
| None | Lung Cancer | View |
| None | Limited Disease Sensitive Small Cell Lung Cancer | View |
| None | Extensive Disease Sensitive Small Cell Lung Cancer | View |
| None | Limited Disease Refractory Small Cell Lung Cancer | View |
| None | Extensive Disease Refractory Small Cell Lung Cancer | View |
| None | Refractory Small Cell Lung Cancer | View |
| None | Sensitive Small Cell Lung Cancer | View |